Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-r4mrb Total loading time: 0 Render date: 2025-03-09T14:45:05.757Z Has data issue: false hasContentIssue false

15 - Betaherpes viral genes and their functions

from Part II - Basic virology and viral gene effects on host cell functions: betaherpesviruses

Published online by Cambridge University Press:  24 December 2009

By
Edward S. Mocarski Jr.
Edited by
Ann Arvin ,
Gabriella Campadelli-Fiume ,
Edward Mocarski ,
Patrick S. Moore ,
Bernard Roizman ,
Richard Whitley  and
Koichi Yamanishi
Edward S. Mocarski Jr.
Affiliation:
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
Ann Arvin
Affiliation:
Stanford University, California
Gabriella Campadelli-Fiume
Affiliation:
Università degli Studi, Bologna, Italy
Edward Mocarski
Affiliation:
Emory University, Atlanta
Patrick S. Moore
Affiliation:
University of Pittsburgh
Bernard Roizman
Affiliation:
University of Chicago
Richard Whitley
Affiliation:
University of Alabama, Birmingham
Koichi Yamanishi
Affiliation:
University of Osaka, Japan
Get access

Summary

Introduction

Despite biological divergence, human cytomegalovirus (HCMV, HHV-5), on the one hand, and the three human roseolaviruses (HHV-6A, HHV-6B, HHV-7), on the other hand, share approximately 70 evolutionarily conserved and collinear genes (italics, Table 15.1). Mammalian betaherpesviruses probably have a common ancestor dating back over 50 million years. The genomes of all betaherpesviruses vary in the regions flanking a large conserved block of genes spanning UL23 to UL124 in HCMV. There appear to be two distinct evolutionary lineages represented by cytomegaloviruses and roseolaviruses infecting primates (Chapter 14). These lineages are not preserved in lower mammals such as rodents where divergence within the cytomegaloviruses is striking. Similarity between rodent cytomegaloviruses and either primate cytomegaloviruses or roseolaviruses is about the same, and includes the same set of 70 conserved genes. Thus, despite the fact that this subgroup of herpesviruses is the most highly distributed amongst mammals, evolutionary divergence is dramatic. The betaherpesvirus-common genes are composed of 41 herpesvirus core functions discussed in Chapters 3, 4and 14 plus approximately 30 betaherpesvirus-specific gene products that are involved in replication and cell tropism. Biological similarities include tropism for hematopoietic cells in the myeloid lineage (Kondo et al., 2002a; Sissons et al., 2002). In addition to the 70 conserved replication genes human betaherpesviruses HCMV and HHV-6B also have latent genes with a common structure and genomic location (Kondo et al., 1996, 2002b 2003b) suggesting evolutionary conservation in this important process as well.

Type
Chapter
Information
Human Herpesviruses
Biology, Therapy, and Immunoprophylaxis
 , pp. 204 - 230
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abate, D. A., Watanabe, S., and Mocarski, E. S. (2004). Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J. Virol., 78, 10995–11006.CrossRefGoogle ScholarPubMed
Adair, R., Douglas, E. R., Maclean, J. B.et al. (2002). The products of human cytomegalovirus genes UL23, UL24, UL43 and US22 are tegument components. J. Gen. Virol., 83, 1315–1324.CrossRefGoogle ScholarPubMed
Adair, R., Liebisch, G. W., and Colberg-Poley, A. M. (2003). Complex alternative processing of human cytomegalovirus UL37 pre-mRNA. J. Gen. Virol., 84, 3353–3358.CrossRefGoogle ScholarPubMed
Agulnick, A. D., Thompson, J. R., Iyengar, S., Pearson, G., Ablashi, D., and Ricciardi, R. P. (1993). Identification of a DNA-binding protein of human herpesvirus 6, a putative DNA polymerase stimulatory factor. J. Gen. Virol., 74(6), 1003–1009.CrossRefGoogle ScholarPubMed
Ahn, J. H. and Hayward, G. S. (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology, 274, 39–55.CrossRefGoogle ScholarPubMed
Ahn, J. H., Jang, W. J., and Hayward, G. S. (1999). The human cytomegalovirus IE2 and UL112–113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol., 73, 10458–10471.Google Scholar
Akter, P., Cunningham, C., McSharry, B. P.et al., (2003). Two novel spliced genes in human cytomegalovirus. J. Gen. Virol., 84, 1117–1122.CrossRefGoogle ScholarPubMed
Alderete, J. P., Child, S. J., and Geballe, A. P. (2001). Abundant early expression of gpUL4 from a human cytomegalovirus mutant lacking a repressive upstream open reading frame. J. Virol., 75, 7188–7192.CrossRefGoogle ScholarPubMed
Anders, D. G. and Gibson, W. (1988). Location, transcript analysis, and partial nucleotide sequence of the cytomegalovirus gene encoding an early DNA-binding protein with similarities to ICP8 of herpes simplex virus type 1. J. Virol., 62, 1364–1372.Google ScholarPubMed
Anders, D. G., Kacica, M. A., Pari, G., and Punturieri, S. M. (1992). Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication. J. Virol., 66, 3373–3384.Google ScholarPubMed
Ansari, A. and Emery, V. C. (1999). The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J. Virol., 73, 3284–3291.Google ScholarPubMed
Appleton, B. A., Loregian, A., Filman, D. J., Coen, D. M., and Hogle, J. M. (2004). The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol. Cell, 15, 233–244.CrossRefGoogle Scholar
Atalay, R., Zimmermann, A., Wagner, M.et al. (2002). Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J. Virol., 76, 8596–8608.CrossRefGoogle ScholarPubMed
AuCoin, D. P., Smith, G. B., Meiering, C. D., and Mocarski, E. S. (2006). Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J. Virol., 80, 8199–8821.CrossRefGoogle ScholarPubMed
Baek, M. C., Krosky, P. M., Pearson, A., and Coen, D. M. (2004). Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase. Virology, 324, 184–193.CrossRefGoogle ScholarPubMed
Baldick, C. J. Jr., and Shenk, T. (1996). Proteins associated with purified human cytomegalovirus particles. J. Virol., 70, 6097–6105.Google ScholarPubMed
Baldick, C. J. Jr., Marchini, A., Patterson, C. E., and Shenk, T. (1997). Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J. Virol., 71, 4400–4408.Google ScholarPubMed
Baldwin, B. R., Zhang, C. O., and Keay, S. (2000). Cloning and epitope mapping of a functional partial fusion receptor for human cytomegalovirus gH. J. Gen. Virol., 81, 27–35.CrossRefGoogle ScholarPubMed
Barrasa, M. I., Harel, N. Y., and Alwine, J. C. (2005). The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate–early protein IE2/IEP86 affects temporal viral gene expression. J. Virol., 79, 1428–1437.CrossRefGoogle ScholarPubMed
Battista, M. C., Bergamini, G., Boccuni, M. C., Campanini, F., Ripalti, A., and Landini, M. P. (1999). Expression and characterization of a novel structural protein of human cytomegalovirus, pUL25. J. Virol., 73, 3800–3809.Google ScholarPubMed
Baxter, M. K. and Gibson, W. (2001). Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third. J. Virol., 75, 6865–6873.CrossRefGoogle ScholarPubMed
Bechtel, J. T. and Shenk, T. (2002). Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression. J. Virol., 76, 1043–1050.CrossRefGoogle ScholarPubMed
Biegalke, B. J., Lester, E., Branda, A., and Rana, R. (2004). Characterization of the human cytomegalovirus UL34 gene. J. Virol., 78, 9579–9583.CrossRefGoogle ScholarPubMed
Billstrom, M. A., Lehman, L. A., and Worthen, S. G. (1999). Depletion of extracellular RANTES during human cytomegalovirus infection of endothelial cells. Am. J. Respir. Cell. Mol. Biol., 21, 163–167.CrossRefGoogle ScholarPubMed
Blankenship, C. A. and Shenk, T. (2002). Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect. J. Virol., 76, 12290–12299.CrossRefGoogle ScholarPubMed
Boehme, K. W., Singh, J., Perry, S. T., and Compton, T. (2004). Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J. Virol., 78, 1202–1211.CrossRefGoogle ScholarPubMed
Boehmer, P. E. and Nimonkar, A. V. (2003). Herpes virus replication. IUBMB Life, 55, 13–22.CrossRefGoogle ScholarPubMed
Bogner, E. (2002). Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev. Med. Virol., 12, 115–127.CrossRefGoogle ScholarPubMed
Bogner, E., Radsak, K., and Stinski, M. F. (1998). The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J. Virol., 72, 2259–2264.Google ScholarPubMed
Bolovan-Fritts, C. A., and Wiedeman, J. A. (2002). Mapping the viral genetic determinants of endothelial cell tropism in human cytomegalovirus. J. Clin. Virol., 25 Suppl 2, S97–109.CrossRefGoogle ScholarPubMed
Borst, E. M., Hahn, G., Koszinowski, U. H., and Messerle, M. (1999). Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol., 73, 8320–8329.Google ScholarPubMed
Boyle, K. A., Pietropaolo, R. L., and Compton, T. (1999). Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell Biol., 19, 3607–3613.CrossRefGoogle ScholarPubMed
Bresnahan, W. A. and Shenk, T. E. (2000). UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cellsProc. Natl Acad. Sci. USA, 97, 14506–14511.CrossRefGoogle ScholarPubMed
Britt, W. J. and Mach, M. (1996). Human cytomegalovirus glycoproteins. Intervirology, 39, 401–412.CrossRefGoogle ScholarPubMed
Britt, W. J., Jarvis, M., Seo, J. Y., Drummond, D., and Nelson, J. (2004). Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: demonstration that pp28 (UL99) is essential for production of infectious virus. J. Virol., 78, 539–543.CrossRefGoogle ScholarPubMed
Brown, J. M., Kaneshima, H., and Mocarski, E. S. (1995). Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J. Infect. Dis., 171, 1599–1603.CrossRefGoogle ScholarPubMed
Brune, W., Menard, C., Heesemann, J., and Koszinowski, U. H. (2001). A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science, 291, 303–305.CrossRefGoogle ScholarPubMed
Buerger, I., Reefschlaeger, J., Bender, W.et al., (2001). A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J. Virol., 75, 9077–9086.CrossRefGoogle ScholarPubMed
Caposio, P., Riera, L., Hahn, G., Landolfo, S., and Gribaudo, G. (2004). Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. Virology, 325, 264–276.CrossRefGoogle Scholar
Casaday, R. J., Bailey, J. R., Kalb, S. R.et al., (2004). Assembly protein precursor (pUL80.5 homolog) of simian cytomegalovirus is phosphorylated at a glycogen synthase kinase 3 site and its downstream “priming” site: phosphorylation affects interactions of protein with itself and with major capsid protein. J. Virol., 78, 13501–13511.CrossRefGoogle Scholar
Casarosa, P., Bakker, R. A., Verzijl, D.et al., (2001). Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J. Biol. Chem., 276, 1133–1137.CrossRefGoogle ScholarPubMed
Casarosa, P., Gruijthuijsen, Y. K., Michel, D.et al., (2003). Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. J. Biol. Chem., 278, 50010–50023.CrossRefGoogle ScholarPubMed
Cavanaugh, V. J., Stenberg, R. M., Staley, T. L.et al., (1996). Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism. J. Virol., 70, 1365–1374.Google ScholarPubMed
Cha, T. A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., and Spaete, R. R. (1996). Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol., 70, 78–83.Google Scholar
Chang, W. L., Baumgarth, N., Yu, D., and Barry, P. A. (2004). Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol., 78, 8720–8731.CrossRefGoogle ScholarPubMed
Chee, M. S., Bankier, A. T., Beck, S.et al., (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol., 154, 125–170.Google ScholarPubMed
Child, S. J., Jarrahian, S., Harper, V. M., and Geballe, A. P. (2002). Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus. J. Virol., 76, 4912–4918.CrossRefGoogle ScholarPubMed
Child, S. J., Hakki, M., Niro, K. L., and Geballe, A. P. (2004). Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol., 78, 197–205.CrossRefGoogle ScholarPubMed
Chou, S., Marousek, G. I., Senters, A. E., Davis, M. G., and Biron, K. K. (2004). Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir. J. Virol., 78, 7124–7130.CrossRefGoogle ScholarPubMed
Colberg-Poley, A. M., Huang, L., Soltero, V. E., Iskenderian, A. C., Schumacher, R. F., and Anders, D. G. (1998). The acidic domain of pUL37 × 1 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructionsVirology, 246, 400–408.CrossRefGoogle Scholar
Colletti, K. S., Xu, Y., Cei, S. A., Tarrant, M., and Pari, G. S. (2004). Human cytomegalovirus UL84 oligomerization and heterodimerization domains act as transdominant inhibitors of oriLyt-dependent DNA replication: evidence that IE2-UL84 and UL84-UL84 interactions are required for lytic DNA replication. J. Virol., 78, 9203–9214.CrossRefGoogle ScholarPubMed
Colletti, K. S., Xu, Y., Yamboliev, I., and Pari, G. S. (2005). Human cytomegalovirus UL84 Is a phosphoprotein that exhibits UTPase activity and is a putative member of the DExD/H box family of proteins. J. Biol. Chem., 280, 11955–11960.CrossRefGoogle ScholarPubMed
Compton, T. (2004). Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell Biol., 14, 5–8.CrossRefGoogle ScholarPubMed
Compton, T., Nepomuceno, R. R., and Nowlin, D. M. (1992). Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology, 191, 387–395.CrossRefGoogle ScholarPubMed
Compton, T., Nowlin, D. M., and Cooper, N. R. (1993). Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193, 834–841.CrossRefGoogle ScholarPubMed
Compton, T., Kurt-Jones, E. A., Boehme, K. W.et al., (2003). Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J. Virol., 77, 4588–4596.CrossRefGoogle ScholarPubMed
Conti, C., Cirone, M., Sgro, R., Altieri, F., Zompetta, C., and Faggioni, A. (2000). Early interactions of human herpesvirus 6 with lymphoid cells: role of membrane protein components and glycosaminoglycans in virus binding. J. Med. Virol., 62, 487–497.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Courcelle, C. T., Courcelle, J., Prichard, M. N., and Mocarski, E. S. (2001). Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J. Virol., 75, 7592–7601.CrossRefGoogle ScholarPubMed
Monte, P., Pignatelli, S., Zini, N.et al. (2002). Analysis of intracellular and intraviral localization of the human cytomegalovirus UL53 protein. J. Gen. Virol., 83, 1005–1012.CrossRefGoogle Scholar
Monte, P., Pignatelli, S., Rossini, G., and Landini, M. P. (2004). Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm. Hum. Immunol., 65, 387–394.CrossRefGoogle Scholar
Dargan, D. J., Jamieson, F. E., MacLean, J., Dolan, A., Addison, C., and McGeoch, D. J. (1997). The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J. Virol., 71, 9833–9836.Google ScholarPubMed
Davison, A. J., Dolan, A., Akter, P.et al., (2003). The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol., 84, 17–28.CrossRefGoogle ScholarPubMed
Dewhurst, S., Dollard, S. C., Pellett, P. E., and Dambaugh, T. R. (1993). Identification of a lytic-phase origin of DNA replication in human herpesvirus 6B strain Z29. J. Virol., 67, 7680–7683.Google ScholarPubMed
Dhepakson, P., Mori, Y., Jiang, Y. B.et al., (2002). Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J. Gen. Virol., 83, 847–854.CrossRefGoogle ScholarPubMed
Dittmer, A. and Bogner, E. (2005). Analysis of the quaternary structure of the putative HCMV portal protein pUL104. Biochemistry, 44, 759–765.CrossRefGoogle ScholarPubMed
Dolan, A., Cunningham, C., Hector, R. D.et al., (2004). Genetic content of wild-type human cytomegalovirus. J. Gen. Virol., 85, 1301–1312.CrossRefGoogle ScholarPubMed
Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999a). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol., 73, 8040–8052.Google Scholar
Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999b). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol., 73, 8040–8052.Google Scholar
Doniger, J., Muralidhar, S., and Rosenthal, L. J. (1999). Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin. Microbiol. Rev., 12, 367–382.Google ScholarPubMed
Dunn, C., Chalupny, N. J., Sutherland, C. L.et al., (2003a). Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med., 197, 1427–1439.CrossRefGoogle Scholar
Dunn, W., Chou, C., Li, H.et al., (2003b). Functional profiling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. USA, 100, 14223–14228.CrossRefGoogle Scholar
Dykes, C., Chan, H., Krenitsky, D. M., and Dewhurst, S. (1997). Stringent structural and sequence requirements of the human herpesvirus 6B lytic-phase origin of DNA replication. J. Gen. Virol., 78(5), 1125–1129.CrossRefGoogle ScholarPubMed
Evers, D. L., Wang, X., and Huang, E. S. (2004). Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 6, 1084–1093.CrossRefGoogle ScholarPubMed
Feire, A. L., Koss, H., and Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl Acad. Sci. USA, 101, 15470–15475.CrossRefGoogle Scholar
Flebbe-Rehwaldt, L. M., Wood, C., and Chandran, B. (2000). Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16–U17 open reading frames. J. Virol., 74, 11040–11054.CrossRefGoogle Scholar
Fortunato, E. A., Sanchez, V., Yen, J. Y., and Spector, D. H. (2002). Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J. Virol., 76, 5369–5379.CrossRefGoogle Scholar
Fraile-Ramos, A., Pelchen-Matthews, A., Kledal, T. N., Browne, H., Schwartz, T. W., and Marsh, M. (2002). Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes. Traffic, 3, 218–232.CrossRefGoogle ScholarPubMed
French, C., Menegazzi, P., Nicholson, L., Macaulay, H., DiLuca, D., and Gompels, U. A. (1999). Novel, nonconsensus cellular splicing regulates expression of a gene encoding a chemokine-like protein that shows high variation and is specific for human herpesvirus 6. Virology, 262, 139–151.CrossRefGoogle ScholarPubMed
Furman, M. H., Dey, N., Tortorella, D., and Ploegh, H. L. (2002). The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J. Virol., 76, 11753–11756.CrossRefGoogle ScholarPubMed
Gao, J. L. and Murphy, P. M. (1994). Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem., 269, 28539–28542.Google ScholarPubMed
Gao, M., Robertson, B. J., McCann, P. J.et al., (1998). Functional conservations of the alkaline nuclease of herpes simplex type 1 and human cytomegalovirus. Virology, 249, 460–470.CrossRefGoogle ScholarPubMed
Gawn, J. M. and Greaves, R. F. (2002). Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed–early gene expression. J. Virol., 76, 4441–4455.CrossRefGoogle Scholar
Gebert, S., Schmolke, S., Sorg, G., Floss, S., Plachter, B., and Stamminger, T. (1997). The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate–early-mediated transactivation that is able to prevent viral replication. J. Virol., 71, 7048–7060.Google ScholarPubMed
Gerna, G., Percivalle, E., Sarasini, A., Baldanti, F., Campanini, G., and Revello, M. G. (2003). Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. J. Gen. Virol., 84, 1431–1436.CrossRefGoogle ScholarPubMed
Gewurz, B. E., Gaudet, R., Tortorella, D., Wang, E. W., and Ploegh, H. L. (2001). Virus subversion of immunity: a structural perspective. Curr. Opin. Immunol., 13, 442–450.CrossRefGoogle ScholarPubMed
Gibson, W. (1996). Structure and assembly of the virion. Intervirology, 39, 389–400.CrossRefGoogle ScholarPubMed
Gibson, W., Baxter, M. K., and Clopper, K. S. (1996). Cytomegalovirus “missing” capsid protein identified as heat-aggregable product of human cytomegalovirus UL46. J. Virol., 70, 7454–7461.Google ScholarPubMed
Goldmacher, V. S., Bartle, L. M., Skaletskaya, A.et al., (1999). A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci. USA, 96, 12536–12541.CrossRefGoogle Scholar
Gompels, U. A. and Macaulay, H. A. (1995). Characterization of human telomeric repeat sequences from human herpesvirus 6 and relationship to replication. J. Gen. Virol., 76, 451–458.CrossRefGoogle ScholarPubMed
Gompels, U. A., Nicholas, J., Lawrence, G.et al., (1995). The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology, 209, 29–51.CrossRefGoogle ScholarPubMed
Gravel, A., Tomoiu, A., Cloutier, N., Gosselin, J., and Flamand, L. (2003). Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator. Virology, 308, 340–353.CrossRefGoogle ScholarPubMed
Greaves, R. F. and Mocarski, E. S. (1998). Defective growth correlates with reduced accumulation of a viral DNA replication protein after low multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol., 72, 366–379.Google ScholarPubMed
Greijer, A. E., Dekkers, C. A., and Middeldrop, J. M. (2000). Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J. Virol., 74, 9078–9082.CrossRefGoogle ScholarPubMed
Grzimek, N. K., Podlech, J., Steffens, H. P., Holtappels, R., Schmalz, S., and Reddehase, M. J. (1999). In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J. Virol., 73, 5043–5055.Google ScholarPubMed
Guo, Y. W. and Huang, E. S. (1993). Characterization of a structurally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. J. Virol., 67, 2043–2054.Google Scholar
Hahn, G., Khan, H., Baldanti, F., Koszinowski, U. H., Revello, M. G., and Gerna, G. (2002). The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J. Virol., 76, 9551–9555.CrossRefGoogle Scholar
Hahn, G., Jarosch, M., Wang, J. B., Berbes, C., and McVoy, M. A. (2003). Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction. J. Virol. Methods, 107, 185–194.CrossRefGoogle ScholarPubMed
Hahn, G., Revello, M. G., Patrone, M.et al., (2004). Human cytomegalovirus UL131–128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol., 78, 10023–10033.CrossRefGoogle ScholarPubMed
Hanson, L. K., Slater, J. S., Karabekian, Z., Ciocco-Schmitt, G., and Campbell, A. E. (2001). Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen. J. Virol., 75, 6292–6302.CrossRefGoogle ScholarPubMed
Hayajneh, W. A., Colberg-Poley, A. M., Skaletskaya, A.et al., (2001a). The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology, 279, 233–240.CrossRefGoogle Scholar
Hayajneh, W. A., Contopoulos-Ioannidis, D. G., Lesperance, M. M., Venegas, A. M., and Colberg-Poley, A. M. (2001b). The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is important for transactivation. J. Gen. Virol., 82, 1569–1579.CrossRefGoogle Scholar
Hayashi, M. L., Blankenship, C., and Shenk, T. (2000). Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycleProc. Natl Acad. Sci. USA, 97, 2692–2696.CrossRefGoogle ScholarPubMed
Hegde, N. R., Tomazin, R. A., Wisner, T. W.et al., (2002). Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol., 76, 10929–10941.CrossRefGoogle ScholarPubMed
Heider, J. A., Bresnahan, W. A., and Shenk, T. E. (2002). Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc. Natl Acad. Sci. USA, 99, 3141–3146.CrossRefGoogle ScholarPubMed
Hertel, L. and Mocarski, E. S. (2004). Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function. J. Virol., 78, 11988–12011.CrossRefGoogle ScholarPubMed
Hertel, L., Lacaille, V. G., Strobl, H., Mellins, E. D., and Mocarski, E. S. (2003). Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol., 77, 7563–7574.CrossRefGoogle ScholarPubMed
Hewitt, E. W., Gupta, S. S., and Lehner, P. J. (2001). The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J., 20, 387–396.CrossRefGoogle ScholarPubMed
Hitomi, S., Kozuka-Hata, H., Chen, Z., Sugano, S., Yamaguchi, N., and Watanabe, S. (1997). Human cytomegalovirus open reading frame UL11 encodes a highly polymorphic protein expressed on the infected cell surface. Arch. Virol., 142, 1407–1427.CrossRefGoogle ScholarPubMed
Hobom, U., Brune, W., Messerle, M., Hahn, G., and Koszinowski, U. H. (2000). Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol., 74, 7720–7729.CrossRefGoogle ScholarPubMed
Hofmann, H., Sindre, H., and Stamminger, T. (2002). Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human daxx. J. Virol., 76, 5769–5783.CrossRefGoogle ScholarPubMed
Huang, L., Zhu, Y., and Anders, D. G. (1996). The variable 3 ends of a human cytomegalovirus oriLyt transcript (SRT) overlap an essential, conserved replicator element. J. Virol., 70, 5272–5281.Google ScholarPubMed
Huber, M. T. and Compton, T. (1998). The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol., 72, 8191–8197.Google ScholarPubMed
Huber, M. T. and Compton T., (1999). Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus. J. Virol., 73, 3886–3892.Google ScholarPubMed
Huber, M. T., Tomazin, R., Wisner, T., Boname, J., and Johnson, D. C. (2002). Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J. Virol., 76, 5748–5758.CrossRefGoogle Scholar
Hudson, A. W., Howley, P. M., and Ploegh, H. L. (2001). A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J. Virol., 75, 12347–12358.CrossRefGoogle Scholar
Ihara, S., Takekoshi, M., Mori, N., Sakuma, S., Hashimoto, J., and Watanabe, Y. (1994). Identification of mutation sites of a temperature-sensitive mutant of HCMV DNA polymerase activity. Arch. Virol., 137, 263–275.CrossRefGoogle ScholarPubMed
Inoue, N. and Pellett, P. E. (1995). Human herpesvirus 6B origin-binding protein: DNA-binding domain and consensus binding sequence. J. Virol., 69, 4619–4627.Google ScholarPubMed
Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N., and Yamanishi, K. (1998). Human herpesvirus 6 open reading frame U12 encodes a functional beta- chemokine receptor. J. Virol., 72, 6104–6112.Google ScholarPubMed
Ishov, A. M., Vladimirova, O. V., and Maul, G. G. (2002). Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J. Virol., 76, 7705–7712.CrossRefGoogle ScholarPubMed
Iskenderian, A. C., Huang, L., Reilly, A., Stenberg, R. M., and Anders, D. G. (1996). Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J. Virol., 70, 383–392.Google ScholarPubMed
Jahn, G., Stenglein, S., Riegler, S., Einsele, H., and Sinzger, C. (1999). Human cytomegalovirus infection of immature dendritic cells and macrophages. Intervirology, 42, 365–372.CrossRefGoogle ScholarPubMed
Janzen, D. M., Frolova, L., and Geballe, A. P. (2002). Inhibition of translation termination mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA. Mol. Cell Biol., 22, 8562–8570.CrossRefGoogle ScholarPubMed
Jarvis, M. A., Jones, T. R., Drummond, D. D.et al., (2004). Phosphorylation of human cytomegalovirus glycoprotein B (gB) at the acidic cluster casein kinase 2 site (Ser900) is required for localization of gB to the trans-Golgi network and efficient virus replication. J. Virol., 78, 285–293.CrossRefGoogle ScholarPubMed
Johnson, R. A., Huong, S. M., and Huang, E. S. (2000). Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol., 74, 1158–1167.CrossRefGoogle ScholarPubMed
Johnson, R. A., Wang, X., Ma, X. L., Huong, S. M., and Huang, E. S. (2001). Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol., 75, 6022–6032.CrossRefGoogle ScholarPubMed
Jones, T. R. and Lee, S. W. (2004). An acidic cluster of human cytomegalovirus UL99 tegument protein is required for trafficking and function. J. Virol., 78, 1488–1502.CrossRefGoogle ScholarPubMed
Kahl, M., Siegel-Axel, D., Stenglein, S., Jahn, G., and Sinzger, C. (2000). Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J. Virol., 74, 7628–7635.CrossRefGoogle ScholarPubMed
Kalejta, R. F. and Shenk, T. (2003). Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl Acad. Sci. USA, 100, 3263–3268.CrossRefGoogle ScholarPubMed
Kari, B. and Gehrz, R. (1993). Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. J. Gen. Virol., 74, 255–264.CrossRefGoogle ScholarPubMed
Kattenhorn, L. M., Mills, R., Wagner, M.et al. (2004). Identification of proteins associated with murine cytomegalovirus virions. J. Virol., 78, 1187–1197.CrossRefGoogle ScholarPubMed
Kawaguchi, Y., Kato, K., Tanaka, M., Kanamori, M., Nishiyama, Y., and Yamanashi, Y. (2003). Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J. Virol., 77, 2359–2368.CrossRefGoogle ScholarPubMed
Kaye, J. F., Gompels, U. A., and Minson, A. C. (1992). Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol., 73, 2693–2698.CrossRefGoogle ScholarPubMed
Kemble, G. W., and Mocarski, E. S. (1989). A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence. J. Virol., 63, 4715–4728.Google ScholarPubMed
Kemble, G. W., McCormick, A. L., Pereira, L., and Mocarski, E. S. (1987). A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene. J. Virol., 61, 3143–3151.Google ScholarPubMed
Kim, K., Trang, P., Umamoto, S., Hai, R., and Liu, F. (2004). RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins. Nucl. Acids Res., 32, 3427–3434.CrossRefGoogle ScholarPubMed
Kledal, T. N., Rosenkilde, M. M., and Schwartz, T. W. (1998). Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett., 441, 209–214.CrossRefGoogle ScholarPubMed
Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., and Drach, J. C. (2003). Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27. J. Virol., 77, 11499–11506.CrossRefGoogle ScholarPubMed
Komazin, G., Townsend, L. B., and Drach, J. C. (2004). Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J. Virol., 78, 710–715.CrossRefGoogle ScholarPubMed
Kondo, K., Xu, J., and Mocarski, E. S. (1996). Human cytomegalovirus latent gene expression in granulocyte–macrophage progenitors in culture and in seropositive individuals. Proc. Natl Acad. Sci. USA, 93, 11137–11142.CrossRefGoogle ScholarPubMed
Kondo, K., Kondo, T., Shimada, K., Amo, K., Miyagawa, H., and Yamanishi, K. (2002a). Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J. Med. Virol., 67, 364–369.CrossRefGoogle Scholar
Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K., and Yamanishi, K. (2002b). Identification of human herpesvirus 6 latency-associated transcripts. J. Virol., 76, 4145–4151.CrossRefGoogle Scholar
Kondo, K., Nozaki, H., Shimada, K., and Yamanishi, K. (2003a). Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency. J. Virol., 77, 10719–10724.CrossRefGoogle Scholar
Kondo, K., Sashihara, J., Shimada, K.et al., (2003b). Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6. J. Virol., 77, 2258–2264.CrossRefGoogle Scholar
Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., and Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA, 97, 1695–1700.CrossRefGoogle Scholar
Krosky, P. M., Underwood, M. R., Turk, S. R.et al. (1998). Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol., 72, 4721–4728.Google ScholarPubMed
Krosky, P. M., Ptak, R. G., Underwood, M. R., Biron, K. K., Townsend, L. B., and Drach, J. C. (2000). Differences in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and Towne. Antivir Chem Chemother, 11, 349–352.CrossRefGoogle ScholarPubMed
Krosky, P. M., Baek, M. C., and Coen, D. M. (2003a). The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol., 77, 905–914.CrossRefGoogle Scholar
Krosky, P. M., Baek, M. C., Jahng, W. J.et al., (2003b). The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J. Virol., 77, 7720–7727.CrossRefGoogle Scholar
Krug, L. T., Inoue, N., and Pellett, P. E. (2001). Differences in DNA binding specificity among Roseolovirus origin binding proteins. Virology, 288, 145–153.CrossRefGoogle ScholarPubMed
Lai, L. and Britt, W. J. (2003). The interaction between the major capsid protein and the smallest capsid protein of human cytomegalovirus is dependent on two linear sequences in the smallest capsid protein. J. Virol., 77, 2730–2735.CrossRefGoogle ScholarPubMed
Landini, M. P., Lazzarotto, T., Xu, J., Geballe, A. P., and Mocarski, E. S. (2000). Humoral immune response to proteins of human cytomegalovirus latency-associated transcriptsBiol. Blood Marrow Transpl., 6, 100–108.CrossRefGoogle ScholarPubMed
LaPierre, L. A. and Biegalke, B. J. (2001). Identification of a novel transcriptional repressor encoded by human cytomegalovirus. J. Virol., 75, 6062–6069.CrossRefGoogle ScholarPubMed
Lee, H. R. and Ahn, J. H. (2004). Sumoylation of the major immediate-early IE2 protein of human cytomegalovirus Towne strain is not required for virus growth in cultured human fibroblasts. J. Gen. Virol., 85, 2149–2154.CrossRefGoogle Scholar
Lembo, D., Donalisio, M., Hofer, A.et al. (2004). The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J. Virol., 78, 4278–4288.CrossRefGoogle Scholar
Li, J., Yamamoto, T., Ohtsubo, K., Shirakata, M., and Hirai, K. (1999). Major product pp43 of human cytomegalovirus U(L)112–113 gene is a transcriptional coactivator with two functionally distinct domains. Virology, 260, 89–97.CrossRefGoogle ScholarPubMed
Lilley, B. N., Ploegh, H. L., and Tirabassi, R. S. (2001). Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J. Virol., 75, 11218–11221.CrossRefGoogle ScholarPubMed
Lin, K. and Ricciardi, R. P. (1998). The 41-kDa protein of human herpesvirus 6 specifically binds to viral DNA polymerase and greatly increases DNA synthesis. Virology, 250, 210–219.CrossRefGoogle ScholarPubMed
Lischka, P., Rosorius, O., Trommer, E., and Stamminger, T. (2001). A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69. EMBO J., 20, 7271–7283.CrossRefGoogle ScholarPubMed
Littler, E., Lawrence, G., Liu, M. Y., Barrell, B. G., and Arrand, J. R. (1990). Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J. Virol., 64, 714–722.Google ScholarPubMed
Liu, B. and Stinski, M. F. (1992). Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol., 66, 4434–4444.Google ScholarPubMed
Liu, Y. and Biegalke, B. J. (2002). The human cytomegalovirus UL35 gene encodes two proteins with different functions. J. Virol., 76, 2460–2468.CrossRefGoogle ScholarPubMed
Lockridge, K. M., Zhou, S. S., Kravitz, R. H.et al. (2000). Primate cytomegaloviruses encode and express an IL-10-like proteinVirology, 268, 272–280.CrossRefGoogle ScholarPubMed
Lopper, M. and Compton, T. (2004). Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion. J. Virol., 78, 8333–8341.CrossRefGoogle ScholarPubMed
Loregian, A., Appleton, B. A., Hogle, J. M., and Coen, D. M. (2004a). Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44. J. Virol., 78, 158–167.CrossRefGoogle Scholar
Loregian, A., Appleton, B. A., Hogle, J. M., and Coen, D. M. (2004b). Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J. Virol., 78, 9084–9092.CrossRefGoogle Scholar
Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berneman, Z. N., and Gallo, R. C. (1994). CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc. Natl Acad. Sci. USA, 91, 3872–3876.CrossRefGoogle ScholarPubMed
Luttichau, H. R., Clark-Lewis, I., Jensen, P. O., Moser, C., Gerstoft, J., and Schwartz, T. W. (2003). A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J. Biol. Chem., 278, 10928–10933.CrossRefGoogle ScholarPubMed
Mach, M., Kropff, B., Monte, P., and Britt, W. (2000). Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73)J. Virol., 74, 11881–11892.CrossRefGoogle Scholar
Mach, M., Kropff, B., Kryzaniak, M., and Britt, W. (2005). Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects. J. Virol., 79, 2160–2170.CrossRefGoogle Scholar
Maidji, E., Tugizov, S., Abenes, G., Jones, T., and Pereira, L. (1998). A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell- to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J. Virol., 72, 5717–5727.Google ScholarPubMed
Manichanh, C., Olivier-Aubron, C., Lagarde, J. P.et al. (2001). Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J. Gen. Virol., 82, 2767–2776.CrossRefGoogle ScholarPubMed
Manning, W. C., Stoddart, C. A., Lagenaur, L. A., Abenes, G. B., and Mocarski, E. S. (1992). Cytomegalovirus determinant of replication in salivary glands. J. Virol., 66, 3794–3802.Google ScholarPubMed
Marchini, A., Liu, H., and Zhu, H. (2001). Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol., 75, 1870–1878.CrossRefGoogle ScholarPubMed
Masse, M. J., Karlin, S., Schachtel, G. A., and Mocarski, E. S. (1992). Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc. Natl Acad. Sci. USA, 89, 5246–5250.CrossRefGoogle ScholarPubMed
Masse, M. J., Messerle, M., and Mocarski, E. S. (1997). The location and sequence composition of the replicator (orilyst) murine cytomegalovirus. Virology, 230, 350–360.CrossRefGoogle Scholar
McCormick, A. L., Skaletskaya, A., Barry, P. A., Mocarski, E. S., and Goldmacher, V. S. (2003). Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology, 316, 221–233.CrossRefGoogle ScholarPubMed
McCormick, A. L., Meiring, C. D., Smith, G. D., and Mocarskhi, E. S. (2005). Mitochondrial cell death supprenors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J. Virol., 79, 12205–12217.CrossRefGoogle ScholarPubMed
McMahon, T. P. and Anders, D. G. (2002). Interactions between human cytomegalovirus helicase-primase proteins. Virus Res., 86, 39–52.CrossRefGoogle ScholarPubMed
Melnychuk, R. M., Streblow, D. N., Smith, P. P., Hirsch, A. J., Pancheva, D., and Nelson, J. A. (2004). Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J. Virol., 78, 8382–8391.CrossRefGoogle ScholarPubMed
Menard, C., Wagner, M., Ruzsics, Z.et al. (2003). Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol., 77, 5557–5570.CrossRefGoogle ScholarPubMed
Menegazzi, P., Galvan, M., Rotola, A., Ravaioli, T., Gonelli, A., Cassai, E., and Luca, D. (1999). Temporal mapping of transcripts in human herpesvirus-7. J. Gen. Virol., 80(10), 2705–2712.CrossRefGoogle ScholarPubMed
Menotti, L., Mirandola, P., Locati, M., and Campadelli-Fiume, G. (1999). Trafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes. J. Virol., 73, 325–333.Google ScholarPubMed
Mettenleiter, T. C. (2004). Budding events in herpesvirus morphogenesis. Virus Res., 106, 167–180.CrossRefGoogle ScholarPubMed
Michel, D. and Mertens, T. (2004). The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host. Biochim. Biophys. Acta, 1697, 169–180.CrossRefGoogle Scholar
Michel, D., Milotic, I., Wagner, M.et al. (2005). The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. J. Gen. Virol., 86, 297–306.CrossRefGoogle Scholar
Milne, R. S., Paterson, D. A., and Booth, J. C. (1998). Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without. J. Gen. Virol., 79, 855–865.CrossRefGoogle ScholarPubMed
Milne, R. S., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A., and Gompels, U. A. (2000). RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J. Immunol., 164, 2396–2404.CrossRefGoogle ScholarPubMed
Mirandola, P., Menegazzi, P., Merighi, S., Ravaioli, T., Cassai, E., and Luca, D. (1998). Temporal mapping of transcripts in herpesvirus 6 variants. J. Virol., 72, 3837–3844.Google ScholarPubMed
Misaghi, S., Sun, Z. Y., Stern, P., Gaudet, R., Wagner, G., and Ploegh, H. (2004). Structural and functional analysis of human cytomegalovirus US3 protein. J. Virol., 78, 413–423.CrossRefGoogle ScholarPubMed
Mocarski, E. S. (2002). Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol., 10, 332–339.CrossRefGoogle ScholarPubMed
Mocarski, E. S. Jr. (2004). Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol., 6, 707–717.CrossRefGoogle ScholarPubMed
Mocarski, E. S., Liu, A. C., and Spaete, R. R. (1987). Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J. Gen. Virol., 68, 2223–2230.CrossRefGoogle Scholar
Mocarski, E. S., Bonyhadi, M., Salimi, S., McCune, J. M., and Kaneshima, H. (1993). Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc. Natl Acad. Sci. USA, 90, 104–108.CrossRefGoogle Scholar
Mocarski, E. S., Kemble, G. W., Lyle, J. M., and Greaves, R. F. (1996). A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc. Natl Acad. Sci. USA, 93, 11321–11326.CrossRefGoogle ScholarPubMed
Mocarski, E. S., Prichard, M. N., Tan, C. S., and Brown, J. M. (1997). Reassessing the organization of the UL42–UL43 region of the human cytomegalovirus strain AD169 genome. Virology, 239, 169–175.CrossRefGoogle ScholarPubMed
Mocarski, E. S., Hahn, G., White, K. L., Xu, J. et al., (2005) Myeloid cell recruitment and function in pathogenesis and latency. In Cytomegaloviruses: Molecular Biology and Immunology, ed. Reddehase, M. J., Hethersett, Norfolk. UK: Horizon Scientific Press. (in press)Google Scholar
Morello, C. S., Cranmer, L. D., and Spector, D. H. (1999). In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83). J. Virol., 73, 7678–7693.Google Scholar
Mori, Y., Seya, T., Huang, H. L., Akkapaiboon, P., Dhepakson, P., and Yamanishi, K. (2002). Human herpesvirus 6 variant A, but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, C046. J. Virol., 76, 6750–6761.CrossRefGoogle Scholar
Mori, Y., Akkapaiboon, P., Yang, X., and Yamanishi, K. (2003a). The human herpesvirus 6 U100 gene product is the third component of the gH–gL glycoprotein complex on the viral envelope. J. Virol., 77, 2452–2458.CrossRefGoogle Scholar
Mori, Y., Yang, X., Akkapaiboon, P., Okuno, T., and Yamanishi, K. (2003b). Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J. Virol., 77, 4992–4999.CrossRefGoogle Scholar
Mori, Y., Akkapaiboon, P., Yonemoto, S.et al., (2004). Discovery of a second form of tripartite complex containing gH–gL of human herpesvirus 6 and observations on CD46. J. Virol., 78, 4609–4616.CrossRefGoogle ScholarPubMed
Mukai, T., Isegawa, Y., and Yamanishi, K. (1995). Identification of the major capsid protein gene of human herpesvirus 7. Virus Res., 37, 55–62.CrossRefGoogle ScholarPubMed
Muranyi, W., Haas, J., Wagner, M., Krohne, G., and Koszinowski, U. H. (2002). Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science, 297, 854–857.CrossRefGoogle ScholarPubMed
Nakano, K., Tadagaki, K., Isegawa, Y., Aye, M. M., Zou, P., and Yamanishi, K. (2003). Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 77, 8108–8115.CrossRefGoogle ScholarPubMed
Navarro, D., Paz, P., Tugizov, S., Topp, K., Vail, J., and Pereira, L. (1993). Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology, 197, 143–158.CrossRefGoogle ScholarPubMed
Neipel, F., Ellinger, K., and Fleckenstein, B. (1992). Gene for the major antigenic structural protein (p100) of human herpesvirus 6. J. Virol., 66, 3918–3924.Google ScholarPubMed
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J. (1993). Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell, 72, 415–425.CrossRefGoogle ScholarPubMed
Nevels, M., Paulus, C., and Shenk, T. (2004). Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc. Natl Acad. Sci. USA, 101, 17234–17239.CrossRefGoogle ScholarPubMed
Neyts, J., Snoeck, R., Schols, D.et al., (1992). Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology, 189, 48–58.CrossRefGoogle ScholarPubMed
Nicholas, J. (1996). Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol., 70, 5975–5989.Google Scholar
Nikolaou, K., Varinou, L., Inoue, N., and Arsenakis, M. (2003). Identification and characterization of gene products of ORF U90/89 of human herpesvirus 6. Acta Virol., 47, 17–26.Google ScholarPubMed
Ogawa-Goto, K., Irie, S., Omori, A.et al., (2002). An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48. J. Virol., 76, 2350–2362.CrossRefGoogle ScholarPubMed
Ogawa-Goto, K., Tanaka, K., Gibson, W.et al., (2003). Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J. Virol., 77, 8541–8547.CrossRefGoogle ScholarPubMed
Oien, N. L., Thomsen, D. R., Wathen, M. W., Newcomb, W. W., Brown, J. C., and Homa, F. L. (1997). Assembly of herpes simplex virus capsids using the human cytomegalovirus scaffold protein: critical role of the C terminus. J. Virol., 71, 1281–1291.Google ScholarPubMed
Papanikolaou, E., Kouvatsis, V., Dimitriadis, G., Inoue, N., and Arsenakis, M. (2002). Identification and characterization of the gene products of open reading frame U86/87 of human herpesvirus 6. Virus Res., 89, 89–101.CrossRefGoogle ScholarPubMed
Pari, G. S. and Anders, D. G. (1993). Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol., 67, 6979–6988.Google ScholarPubMed
Patrone, M., Percivalle, E., Secchi, M.et al., (2003). The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J. Gen. Virol., 84, 3359–3370.CrossRefGoogle ScholarPubMed
Patterson, C. E. and Shenk, T. (1999). Human cytomegalovirus UL36 protein is dispensable for viral replication in cultured cells. J. Virol., 73, 7126–7131.Google ScholarPubMed
Penfold, M. E. and Mocarski, E. S. (1997). Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology, 239, 46–61.CrossRefGoogle ScholarPubMed
Penfold, M. E., Dairaghi, D. J., Duke, G. M.et al., (1999). Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl Acad. Sci. USA, 96, 9839–9844.CrossRefGoogle ScholarPubMed
Pizzorno, M. C., Mullen, M. A., Chang, Y. N., and Hayward, G. S. (1991). The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J. Virol., 65, 3839–3852.Google Scholar
Plafker, S. M. and Gibson, W. (1998). Cytomegalovirus assembly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein. J. Virol., 72, 7722–7732.Google ScholarPubMed
Prichard, M. N., Duke, G. M., and Mocarski, E. S. (1996). Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J. Virol., 70, 3018–3025.Google ScholarPubMed
Prichard, M. N., Jairath, S., Penfold, M. E., Jeor, St S., Bohlman, M. C., and Pari, G. S. (1998). Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol., 72, 6997–7004.Google ScholarPubMed
Prichard, M. N., Gao, N., Jairath, S.et al., (1999). A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J. Virol., 73, 5663–5670.Google Scholar
Prichard, M. N., Penfold, M. E., Duke, G. M., Spaete, R. R., and Kemble, G. W. (2001). A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol., 11, 191–200.CrossRefGoogle ScholarPubMed
Reboredo, M., Greaves, R. F., and Hahn, G. (2004). Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Virol., 85, 3555–3567.CrossRefGoogle ScholarPubMed
Reid, G. G., Ellsmore, V., and Stow, N. D. (2003). An analysis of the requirements for human cytomegalovirus oriLyt-dependent DNA synthesis in the presence of the herpes simplex virus type 1 replication fork proteins. Virology, 308, 303–316.CrossRefGoogle ScholarPubMed
Reinhardt, J., Smith, G. B., Himmelheber, C. T., Azizkhan-Clifford, J., and Mocarski, E. S. (2005). The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication. J. Virol., 79, 225–233.CrossRefGoogle Scholar
Riegler, S., Hebart, H., Einsele, H., Brossart, P., Jahn, G., and Sinzger, C. (2000). Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol., 81, 393–399.CrossRefGoogle ScholarPubMed
Romanowski, M. J. and Shenk, T. (1997). Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J. Virol., 71, 1485–1496.Google ScholarPubMed
Romanowski, M. J., Garrido-Guerrero, E., and Shenk, T. (1997). pIRS1 and pTRS1 are present in human cytomegalovirus virions. J. Virol., 71, 5703–5705.Google ScholarPubMed
Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., and Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl Acad. Sci. USA, 95, 13911–13916.CrossRefGoogle ScholarPubMed
Sampaio, K. L., Cavignac, Y., Stierhof, Y. D., and Sinzger, C. (2005). Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements. J. Virol., 79, 2754–2767.CrossRefGoogle ScholarPubMed
Sanchez, V., Greis, K. D., Sztul, E., and Britt, W. J. (2000a). Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assemblyJ. Virol., 74, 975–986.CrossRefGoogle Scholar
Sanchez, V., Sztul, E., and Britt, W. J. (2000b). Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-Golgi-intermediate compartment. J. Virol., 74, 3842–3851.CrossRefGoogle Scholar
Sanchez, V., Clark, C. L., Yen, J. Y., Dwarakanath, R., and Spector, D. H. (2002). Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication. J. Virol., 76, 2973–2989.CrossRefGoogle ScholarPubMed
Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., and Lusso, P. (1999). CD46 is a cellular receptor for human herpesvirus 6. Cell, 99, 817–827.CrossRefGoogle ScholarPubMed
Santoro, F., Greenstone, H. L., Insinga, A.et al., (2003). Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem., 278, 25964–25969.CrossRefGoogle ScholarPubMed
Sarisky, R. T. and Hayward, G. S. (1996). Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J. Virol., 70, 7398–7413.Google ScholarPubMed
Saverino, D., Ghiotto, F., Merlo, A.et al., (2004). Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol., 172, 5629–5637.CrossRefGoogle ScholarPubMed
Scheffczik, H., Savva, C. G., Holzenburg, A., Kolesnikova, L., and Bogner, E. (2002). The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucl. Acids Res., 30, 1695–1703.CrossRefGoogle ScholarPubMed
Schierling, K., Stamminger, T., Mertens, T., and Winkler, M. (2004). Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J. Virol., 78, 9512–9523.CrossRefGoogle ScholarPubMed
Schierling, K., Buser, C., Mertens, T., and Winkler, M. (2005). Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J. Virol., 79, 3084–3096.CrossRefGoogle ScholarPubMed
Scholz, B., Rechter, S., Drach, J. C., Townsend, L. B., and Bogner, E. (2003). Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucl. Acids Res., 31, 1426–1433.CrossRefGoogle ScholarPubMed
Secchiero, P., Sun, D., Vico, A. L.et al., (1997). Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. J. Virol., 71, 4571–4580.Google ScholarPubMed
Sedy, J. R., Gavrieli, M., Potter, K. G.et al., (2005). B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol., 6, 90–98.CrossRefGoogle Scholar
Silva, M. C., Yu, Q. C., Enquist, L., and Shenk, T. (2003). Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J. Virol., 77, 10594–10605.CrossRefGoogle ScholarPubMed
Silva, M. C., Schroer, J., and Shenk, T. (2005). Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein. Proc. Natl Acad. Sci. USA, 102, 2081–2086.CrossRefGoogle ScholarPubMed
Sinzger, C. and Jahn, G. (1996). Human cytomegalovirus cell tropism and pathogenesis. Intervirology, 39, 302–319.CrossRefGoogle ScholarPubMed
Sinzger, C., Kahl, M., Laib, K.et al., (2000). Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J. Gen. Virol., 81, 3021–3035.CrossRefGoogle ScholarPubMed
Sissons, J. G., Bain, M., and Wills, M. R. (2002). Latency and reactivation of human cytomegalovirus. J. Infect., 44, 73–77.CrossRefGoogle ScholarPubMed
Skaletskaya, A., Bartle, L. M., Chittenden, T., McCormick, A. L., Mocarski, E. S., and Goldmacher, V. S. (2001). A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl Acad. Sci. USA, 98, 7829–7834.CrossRefGoogle ScholarPubMed
Smith, J. A., Jairath, S., Crute, J. J., and Pari, G. S. (1996). Characterization of the human cytomegalovirus UL105 gene and identification of the putative helicase protein. Virology, 220, 251–255.CrossRefGoogle ScholarPubMed
Spaderna, S., Blessing, H., Bogner, E., Britt, W., and Mach, M. (2002). Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus. J. Virol., 76, 1450–1460.CrossRefGoogle ScholarPubMed
Spaderna, S., Hahn, G., and Mach, M. (2004). Glycoprotein gpTRL10 of human cytomegalovirus is dispensable for virus replication in human fibroblasts. Arch. Virol., 149, 495–506.CrossRefGoogle ScholarPubMed
Spector, D. J. and Tevethia, M. J. (1994). Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J. Virol., 68, 7549–7553.Google ScholarPubMed
Spencer, J. V., Lockridge, K. M., Barry, P. A.et al., (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol., 76, 1285–1292.CrossRefGoogle ScholarPubMed
Stamey, F. R., Dominguez, G., Black, J. B., Dambaugh, T. R., and Pellett, P. E. (1995). Intragenomic linear amplification of human herpesvirus 6B oriLyt suggests acquisition of oriLyt by transposition. J. Virol., 69, 589–596.Google ScholarPubMed
Stamminger, T., Gstaiger, M., Weinzierl, K., Lorz, K., Winkler, M., and Schaffner, W. (2002). Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain. J. Virol., 76, 4836–4847.CrossRefGoogle ScholarPubMed
Stasiak, P. C. and Mocarski, E. S. (1992). Transactivation of the cytomegalovirus ICP36 gene promoter requires the α gene product TRS1 in addition to IE1 and IE2. J. Virol., 66, 1050–1058.Google ScholarPubMed
Stefan, A., Secchiero, P., Baechi, T., Kempf, W., and Campadelli-Fiume, G. (1997). The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles. J. Virol., 71, 5758–5763.Google ScholarPubMed
Streblow, D. N., Soderberg-Naucler, C., Vieira, J.et al., (1999). The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell, 99, 511–520.CrossRefGoogle ScholarPubMed
Strive, T., Gicklhorn, D., Wohlfahrt, M. et al. (2004). Site directed mutagenesis of the carboxyl terminus of human cytomegalovirus glycoprotein B leads to attenuation of viral growth in cell culture. Arch. Virol.
Sun, Y. and Conner, J. (1999). The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit. J. Gen. Virol., 80(10), 2713–2718.CrossRefGoogle Scholar
Takemoto, M., Shimamoto, T., Isegawa, Y., and Yamanishi, K. (2001). The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J. Virol., 75, 10149–10160.CrossRefGoogle ScholarPubMed
Talarico, C. L., Burnette, T. C., Miller, W. H.et al., (1999). Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob. Agents Chemother., 43, 1941–1946.Google ScholarPubMed
Taniguchi, T., Shimamoto, T., Isegawa, Y., Kondo, K., and Yamanishi, K. (2000). Structure of transcripts and proteins encoded by U79–80 of human herpesvirus 6 and its subcellular localization in infected cells. Virology, 271, 307–320.CrossRefGoogle ScholarPubMed
Terhune, S. S., Schroer, J., and Shenk, T. (2004). RNAs are packaged into human cytomegalovirus virions in proportion to their intracellular concentration. J. Virol., 78, 10390–10398.CrossRefGoogle ScholarPubMed
Theiler, R. N. and Compton, T. (2002). Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells. J. Virol., 76, 2890–2898.CrossRefGoogle Scholar
Tigue, N. J., Matharu, P. J., Roberts, N. A., Mills, J. S., Kay, J., and Jupp, R. (1996). Cloning, expression and characterization of the proteinase from human herpesvirus 6. J. Virol., 70, 4136–4141.Google ScholarPubMed
Tirabassi, R. S. and Ploegh, H. L. (2002). The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products. J. Virol., 76, 6832–6835.CrossRefGoogle ScholarPubMed
Tirosh, B., Iwakoshi, N. N., Lilley, B. N., Lee, A. H., Glimcher, L. H., and Ploegh, H. L. (2005). Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class I major histocompatibility complex products. J. Virol., 79, 2768–2779.CrossRefGoogle ScholarPubMed
Tomasec, P., Braud, V. M., Rickards, C.et al., (2000). Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science, 287, 1031–1033.CrossRefGoogle ScholarPubMed
Tomasec, P., Wang, E. C., Davison, A. J.et al., (2005). Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol., 6, 181–188.CrossRefGoogle ScholarPubMed
Tooze, J., Hollinshead, M., Reis, B., Radsak, K., and Kern, H. (1993). Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol., 60, 163–178.Google ScholarPubMed
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., and Ploegh, H. L. (2000). Viral subversion of the immune system. Annu. Rev. Immunol., 18, 861–926.CrossRefGoogle ScholarPubMed
Tugizov, S., Navarro, D., Paz, P., Wang, Y., Qadri, I., and Pereira, L. (1994). Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology, 201, 263–276.CrossRefGoogle ScholarPubMed
Ulbrecht, M., Martinozzi, S., Grzeschik, M.et al., (2000). Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol., 164, 5019–5022.CrossRefGoogle ScholarPubMed
Ulbrecht, M., Hofmeister, V., Yuksekdag, G.et al., (2003). HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum. Immunol., 64, 231–237.CrossRefGoogle Scholar
Vales-Gomez, M., Browne, H., and Reyburn, H. T. (2003). Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol., 4, 4.CrossRefGoogle ScholarPubMed
Vales-Gomez, M., Shiroishi, M., Maenaka, K., and Reyburn, H. T. (2005). Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J. Virol., 79, 2251–2260.CrossRefGoogle Scholar
Loon, N., Dykes, C., Deng, H., Dominguez, G., Nicholas, J., and Dewhurst, S. (1997). Identification and analysis of a lytic-phase origin of DNA replication in human herpesvirus 7. J. Virol., 71, 3279–3284.Google ScholarPubMed
Varnum, S. M., Streblow, D. N., Monroe, M. E.et al., (2004). Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol., 78, 10960–10966.CrossRefGoogle ScholarPubMed
Vieira, J., Schall, T. J., Corey, L., and Geballe, A. P. (1998). Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol., 72, 8158–8165.Google ScholarPubMed
Wang, D., Bresnahan, W., and Shenk, T. (2004a). Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl Acad. Sci. USA, 101, 16642–16647.CrossRefGoogle Scholar
Wang, E. C., McSharry, B., Retiere, C.et al., (2002). UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl Acad. Sci. USA, 99, 7570–7575.CrossRefGoogle ScholarPubMed
Wang, S. K., Duh, C. Y., and Wu, C. W. (2004b). Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J. Virol., 78, 9750–9762.CrossRefGoogle Scholar
Wang, X., Huong, S. M., Chiu, M. L., Raab-Traub, N., and Huang, E. S. (2003). Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature, 424, 456–461.CrossRefGoogle ScholarPubMed
White, E. A., Clark, C. L., Sanchez, V., and Spector, D. H. (2004). Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J. Virol., 78, 1817–1830.CrossRefGoogle ScholarPubMed
Willcox, B. E., Thomas, L. M., and Bjorkman, P. J. (2003). Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol., 4, 913–919.CrossRefGoogle ScholarPubMed
Wing, B. A. and Huang, E. S. (1995). Analysis and mapping of a family of 3′-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol., 69, 1521–1531.Google ScholarPubMed
Wing, B. A., Lee, G. C., and Huang, E. S. (1996). The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J. Virol., 70, 3339–3345.Google ScholarPubMed
Wing, B. A., Johnson, R. A., and Huang, E. S. (1998). Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J. Virol., 72, 1814–1825.Google ScholarPubMed
Wolf, D. G., Honigman, A., Lazarovits, J., Tavor, E., and Panet, A. (1998). Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase. Arch. Virol., 143, 1223–1232.CrossRefGoogle ScholarPubMed
Wolf, D. G., Courcelle, C. T., Prichard, M. N., and Mocarski, E. S. (2001). Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc. Natl Acad. Sci. USA, 98, 1895–1900.CrossRefGoogle ScholarPubMed
Wood, L. J., Baxter, M. K., Plafker, S. M., and Gibson, W. (1997). Human cytomegalovirus capsid assembly protein precursor (pUL80.5) interacts with itself and with the major capsid protein (pUL86) through two different domains. J. Virol., 71, 179–190.Google ScholarPubMed
Xu, Y., Cei, S. A., Huete, A. R., and Pari, G. S. (2004a). Human cytomegalovirus UL84 insertion mutant defective for viral DNA synthesis and growth. J. Virol., 78, 10360–10369.CrossRefGoogle Scholar
Xu, Y., Cei, S. A., Huete, Rodriguez A., Colletti, K. S., and Pari, G. S. (2004b). Human cytomegalovirus DNA replication requires transcriptional activation via an IE2- and UL84-responsive bidirectional promoter element within oriLyt. J. Virol., 78, 11664–11677.CrossRefGoogle Scholar
Yoon, J. S., Kim, S. H., Shin, M. C.et al., (2004). Inhibition of herpesvirus-6B RNA replication by short interference RNAs. J. Biochem. Mol. Biol., 37, 383–385.Google ScholarPubMed
Yu, D., Smith, G. A., Enquist, L. W., and Shenk, T. (2002). Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol., 76, 2316–2328.CrossRefGoogle ScholarPubMed
Yu, D., Silva, M. C., and Shenk, T. (2003). Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl Acad. Sci. USA, 100, 12396–12401.CrossRefGoogle ScholarPubMed
Yu, X., Shah, S., Atanasov, I., Lo, P., Liu, F., Britt, W. J., and Zhou, Z. H. (2005). Three-dimensional localization of the smallest capsid protein in the human cytomegalovirus capsid. J. Virol., 79, 1327–1332.CrossRefGoogle ScholarPubMed
Yurochko, A. D. and Huang, E. S. (1999). Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol., 162, 4806–4816.Google ScholarPubMed
Yurochko, A. D., Kowalik, T. F., Huong, S. M., and Huang, E. S. (1995). Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol., 69, 5391–5400.Google ScholarPubMed
Yurochko, A. D., Hwang, E. S., Rasmussen, L., Keay, S., Pereira, L., and Huang, E. S. (1997). The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J. Virol., 71, 5051–5059.Google ScholarPubMed
Zhao, Y. and Biegalke, B. J. (2003). Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa). Virology, 315, 353–361.CrossRefGoogle Scholar
Zini, N., Battista, M. C., Santi, S.et al., (1999). The novel structural protein of human cytomegalovirus, pUL25, is localized in the viral tegument. J. Virol., 73, 6073–6075.Google ScholarPubMed
Zini, N., Santi, S., Riccio, M., Landini, M. P., Battista, M. C., and Maraldi, N. M. (2000). pUL25 immunolocalization in human cytomegalovirus-infected and gene-transfected cells. Arch. Virol., 145, 795–803.CrossRefGoogle ScholarPubMed
Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y., and Yamanishi, K. (1999). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol., 73, 5926–5933.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×